Clinical Trial Update: Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney Injury [NA]

View source ↗

Summary

Clinical trial update comparing tailored versus fixed-dose albumin for cirrhosis with sepsis-associated acute kidney injury; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Liver Cirrhosis

Drugs mentioned

• Human Serum Albumin (human serum albumin)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Liver Cirrhosis, Acute Kidney Injury | NA | Status: NOT_YET_RECRUITING